Grown Rogue International (GRUSF) Profit After Tax (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Profit After Tax of -$2.2 million in Q1 2026, up 100.0% quarter-over-quarter from -$5335.5 billion in Q4 2025, and down 397.95% on a YoY basis from $742870.0 in Q1 2025.
Grown Rogue International (GRUSF) Profit After Tax (2009 - 2026) Analysis & Trends
Grown Rogue International's Profit After Tax history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 397.95% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$2500.4 billion (down 274.74% YoY), while the FY2025 annual figure was -$622811.0, up 96.1% from the prior year.
- Profit After Tax was -$2.2 million for Q1 2026 at Grown Rogue International, up from -$5335.5 billion in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $2835.1 billion in Q3 2025 to a low of -$5335.5 billion in Q4 2025.
- Historically, Profit After Tax has averaged -$211.2 billion across 5 years, with a median of $601273.0 in 2022.
- Biggest YoY gain for Profit After Tax was 524.91% in 2025; the steepest drop was 435882840.1% in 2025.
- A 5-year view of Profit After Tax shows it stood at $601273.0 in 2022, then surged by 113.39% to $1.3 million in 2023, then dropped by 4.59% to $1.2 million in 2024, then tumbled by 435882840.1% to -$5335.5 billion in 2025, then soared by 100.0% to -$2.2 million in 2026.
- The last three Profit After Tax figures came in at -$2.2 million (Q1 2026), -$5335.5 billion (Q4 2025), and $2835.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.21 Mn |
| Dec 31, 2025 | -5,335.55 Bn |
| Sep 30, 2025 | 2,835.15 Bn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 742,870.00 |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | -667.24 Bn |
| Jun 30, 2024 | -5.54 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Oct 31, 2023 | -1.48 Mn |
| Jul 31, 2023 | 257,080.14 |
| Apr 30, 2023 | 411,979.00 |
| Jan 31, 2023 | 746,309.00 |
| Jan 31, 2022 | 601,273.00 |
| Oct 31, 2021 | 877.00 Bn |
| Jul 31, 2021 | 240,294.00 |
| Apr 30, 2021 | 1.44 Mn |
| Jan 31, 2021 | 995,789.00 |
| Oct 31, 2020 | -122,401.00 |